ARCHIVES

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Six Comprehensive Center Asked By Candlelighters For Pediatric Cancer

March 24, 1978

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994